Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02709577

A Study of the GI Sleeve for the Treatment of Type 2 Diabetes

A Pilot Feasibility Sham Controlled Study of the GI Sleeve for the Treatment of Type 2 Diabetes

Sponsor: Hospital Dipreca

Interventions EndoBarrier Gastrointestinal Liner Sham: endoscopy and standard of care

Updated 6 times since 2017 Last updated: Nov 1, 2016 Started: Jan 31, 2007 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Type 2 Diabetes, this trial is completed. The trial is conducted by Hospital Dipreca and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Aug 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Aug 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Dipreca
Morphic Medical Inc.

Data source: Morphic Medical Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.